艾滋病毒相关淋巴瘤

HIV therapy Pub Date : 2010-12-14 DOI:10.2217/HIV.10.54
Belinda Lee, M. Bower, T. Newsom-Davis, M. Nelson
{"title":"艾滋病毒相关淋巴瘤","authors":"Belinda Lee, M. Bower, T. Newsom-Davis, M. Nelson","doi":"10.2217/HIV.10.54","DOIUrl":null,"url":null,"abstract":"Since the introduction of highly active antiretroviral therapy, the natural history of HIV infection has changed dramatically, and with it the epidemiology of HIV-related lymphoma. HIV-related lymphomas have increased as a percentage of first AIDS-defining illness. The most prevalent of the HIV-related lymphomas is diffuse large B-cell non-Hodgkin’s lymphoma, followed by Burkitt’s lymphoma. Although not considered an AIDS-defining illness, Hodgkin’s lymphoma is increasing in incidence in those with HIV infection. Treatment outcome and prognosis has improved significantly over the last decade. Paradigms of therapy have shifted, with approaches aimed at complete remission rather than palliation. This review discusses the biology and changes in epidemiology of HIV-related lymphoma and also reviews other key developments in the management of this disease.","PeriodicalId":88510,"journal":{"name":"HIV therapy","volume":"5 1","pages":"649-659"},"PeriodicalIF":0.0000,"publicationDate":"2010-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"13","resultStr":"{\"title\":\"HIV-related lymphoma\",\"authors\":\"Belinda Lee, M. Bower, T. Newsom-Davis, M. Nelson\",\"doi\":\"10.2217/HIV.10.54\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Since the introduction of highly active antiretroviral therapy, the natural history of HIV infection has changed dramatically, and with it the epidemiology of HIV-related lymphoma. HIV-related lymphomas have increased as a percentage of first AIDS-defining illness. The most prevalent of the HIV-related lymphomas is diffuse large B-cell non-Hodgkin’s lymphoma, followed by Burkitt’s lymphoma. Although not considered an AIDS-defining illness, Hodgkin’s lymphoma is increasing in incidence in those with HIV infection. Treatment outcome and prognosis has improved significantly over the last decade. Paradigms of therapy have shifted, with approaches aimed at complete remission rather than palliation. This review discusses the biology and changes in epidemiology of HIV-related lymphoma and also reviews other key developments in the management of this disease.\",\"PeriodicalId\":88510,\"journal\":{\"name\":\"HIV therapy\",\"volume\":\"5 1\",\"pages\":\"649-659\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-12-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"13\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"HIV therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2217/HIV.10.54\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"HIV therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2217/HIV.10.54","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 13

摘要

自从引入高效抗逆转录病毒疗法以来,HIV感染的自然历史发生了巨大变化,HIV相关淋巴瘤的流行病学也随之发生了变化。艾滋病毒相关淋巴瘤在首次确定艾滋病的疾病中所占的百分比有所增加。hiv相关淋巴瘤中最常见的是弥漫性大b细胞非霍奇金淋巴瘤,其次是伯基特淋巴瘤。虽然霍奇金淋巴瘤不被认为是艾滋病的定义性疾病,但它在艾滋病毒感染者中的发病率正在上升。治疗结果和预后在过去十年中有了显著改善。治疗的范式已经发生了变化,治疗的目标是完全缓解,而不是缓解。这篇综述讨论了hiv相关淋巴瘤的生物学和流行病学的变化,并回顾了这种疾病管理的其他关键进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
HIV-related lymphoma
Since the introduction of highly active antiretroviral therapy, the natural history of HIV infection has changed dramatically, and with it the epidemiology of HIV-related lymphoma. HIV-related lymphomas have increased as a percentage of first AIDS-defining illness. The most prevalent of the HIV-related lymphomas is diffuse large B-cell non-Hodgkin’s lymphoma, followed by Burkitt’s lymphoma. Although not considered an AIDS-defining illness, Hodgkin’s lymphoma is increasing in incidence in those with HIV infection. Treatment outcome and prognosis has improved significantly over the last decade. Paradigms of therapy have shifted, with approaches aimed at complete remission rather than palliation. This review discusses the biology and changes in epidemiology of HIV-related lymphoma and also reviews other key developments in the management of this disease.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信